Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Davis

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|June 10, 1994
2-Azetidinones as inhibitors of cholesterol absorptionD A Burnett, M A Caplen, H R Davis, et al.
Journal of Vascular Surgery|May 1, 1988
Aortic wall metabolism in relation to susceptibility and resistance to experimental atherosclerosisP J Cozzi, R T Lyon, H R Davis, et al.
Biochemical and Biophysical Research Communications|November 30, 1993
NG-nitro-L-arginine methyl ester does not affect balloon catheter-induced intimal hyperplasia in ratsR W Watkins, K Pula, J Cook, et al.
Toxicology|May 12, 2009
An assessment of the carcinogenic potential of ezetimibe using nonclinical data in a weight-of-evidence approachM Halleck, H R Davis, P Kirschmeier, et al.
Biochemical Pharmacology|April 29, 1994
Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamsterR E Burrier, S Deren, D G McGregor, et al.
Arteriosclerosis (Dallas, Tex.)|March 1, 1989
Development of atherosclerosis in genetically hyperlipidemic rabbits during chronic fish-oil ingestionS Rich, J F Miller, S Charous, et al.
Diabetes|May 26, 2001
Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamstersM van Heek, T M Austin, C Farley, et al.
Journal of Medicinal Chemistry|April 4, 1998
Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4 -hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorptionS B Rosenblum, T Huynh, A Afonso, et al.
American Journal of Ophthalmology|January 15, 1991
Human and monkey corneal endothelium expression of low-density lipoprotein receptorsS G Elner, V M Elner, M A Pavilack, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1995
The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestineR E Burrier, A A Smith, D G McGregor, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|June 10, 1994
2-Azetidinones as inhibitors of cholesterol absorptionD A Burnett, M A Caplen, H R Davis, et al.
Journal of Vascular Surgery|May 1, 1988
Aortic wall metabolism in relation to susceptibility and resistance to experimental atherosclerosisP J Cozzi, R T Lyon, H R Davis, et al.
Biochemical and Biophysical Research Communications|November 30, 1993
NG-nitro-L-arginine methyl ester does not affect balloon catheter-induced intimal hyperplasia in ratsR W Watkins, K Pula, J Cook, et al.
Toxicology|May 12, 2009
An assessment of the carcinogenic potential of ezetimibe using nonclinical data in a weight-of-evidence approachM Halleck, H R Davis, P Kirschmeier, et al.
Biochemical Pharmacology|April 29, 1994
Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamsterR E Burrier, S Deren, D G McGregor, et al.
Arteriosclerosis (Dallas, Tex.)|March 1, 1989
Development of atherosclerosis in genetically hyperlipidemic rabbits during chronic fish-oil ingestionS Rich, J F Miller, S Charous, et al.
Diabetes|May 26, 2001
Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamstersM van Heek, T M Austin, C Farley, et al.
Journal of Medicinal Chemistry|April 4, 1998
Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4 -hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorptionS B Rosenblum, T Huynh, A Afonso, et al.
American Journal of Ophthalmology|January 15, 1991
Human and monkey corneal endothelium expression of low-density lipoprotein receptorsS G Elner, V M Elner, M A Pavilack, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1995
The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestineR E Burrier, A A Smith, D G McGregor, et al.
Pageof 6